DelveInsight’s “Celiac Disease (CD) – Epidemiology Insights-2023” report provides an overview of the Celiac Disease and current scenario of the disease in the 7MM, i.e., United States and EU5 countries (France, Germany, Italy, Spain and UK) and Japan. It also includes the global historical and forecasted epidemiological data for the total prevalent cases and diagnosed prevalent cases of Celiac Disease from 2013-2023.
Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection.
DelveInsight forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to XXXX Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
– Report covers the disease overview including pathophysiology, symptoms, diagnosis and disease management.
– It focuses on the detailed historical number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for United States and the EU5 countries from 2013-2016.
– The report also includes forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for US and the EU5 countries from 2017-2023.
Request for a Demo or Sample Copy of Report at: https://www.diligentmarket.com/request-sample-page.php?gturl=13774
Scope of this report: The report provides competitive Epidemiology landscape of Celiac Disease. The report provides the marketed drugs information including its sales, development activities and details of patent expiry. The report provides the insight of current and future market for Celiac Disease. The report provides Epidemiology products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information. Coverage of the Celiac Disease Epidemiology on the basis of target, MOA, route of administration, technology involved and molecule type. The report reviews key players involved in the therapeutics development for Celiac Disease and also provide company profiling. The report also gives the information of dormant Epidemiology projects. Epidemiology products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages and Provides Epidemiology assessment by monotherapy and combination therapy products, stage of development and molecule type.
List of Table:
Table 1:Total Diagnosed Prevalent Cases of Celiac Disease (2013-2023)
Table 2:Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Table 3:Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Table 4:Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Table 5:Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Table 6:Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Table 7:Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
List of Figures
Figure 1: Diagnostic Testing for Celiac Disease
Figure 2: Monitoring of Celiac Disease
Figure 3: Diagnosis and treatment of Refractory Celiac Disease
Figure 4: Iceberg model for Celiac disease epidemiology
Figure 5: Genetic predisposition in Celiac disease
Figure 6:Total Diagnosed Prevalent Cases of Celiac Disease (2013-2023)
Figure 7:Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Figure 8:Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Figure 9:Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Figure 10:Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Figure 11:Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Figure 12:Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Browse Full Report at: https://www.diligentmarket.com/celiac-disease-epidemiology-forecast-to-2023-13774-p.php
Note: Very few studies have been conducted for celiac disease in Japan so a brief discussion about Japan’s Celiac Disease scenario has been discussed but no model has been provided.
DiligentMarket is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making long lasting decision for their businesses.
We advise leading decision makers on their critical issues and opportunities; Research & Development, Strategy Making, Commercial, Operations, Competitive Intelligence, Competitive Landscaping and Mergers & Acquisition across all the Pharma and Biotech industries and geographies. We serve our clients by delivering practical and enduring results, and equipping our clients to grow and lead.
The pharmaceuticals market is in its growth stage and we are uniquely positioned to successfully endeavor the dimensions of the fast growing market by providing cutting-edge market and Epidemiology information, to our clients.
Connect With us on:
+91-750 707 8687